Share Price and Basic Stock Data
Last Updated: October 9, 2025, 8:55 pm
| PEG Ratio | 0.45 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Emkay Global Financial Services Ltd operates within the Finance & Investments sector, currently trading at ₹307 with a market capitalization of ₹782 Cr. The company has shown a fluctuating revenue trajectory, with total sales for FY 2023 at ₹215 Cr and projected sales for FY 2025 estimated at ₹360 Cr, indicating a significant growth outlook. Notably, quarterly sales surged from ₹46.65 Cr in Q1 FY 2024 to ₹90.98 Cr in Q4 FY 2024, reflecting a robust recovery post a dip in FY 2023. The growth trend is expected to continue into FY 2025, with Q1 projected sales reaching ₹72.97 Cr and Q2 estimated at ₹108.02 Cr. This growth trajectory is essential as it positions the company favorably against sector norms, where the average revenue growth in the finance sector is around 10-15% annually, as per recent market analyses.
Profitability and Efficiency Metrics
Emkay’s profitability metrics reveal a mixed performance, with a current operating profit margin (OPM) of 7.99%. The company’s net profit for FY 2023 stood at ₹57 Cr, translating to an EPS of ₹5.71. However, the company experienced negative operating profits in certain quarters, particularly in Q4 FY 2023 where the OPM dropped to -28.09%. Despite these fluctuations, the return on equity (ROE) and return on capital employed (ROCE) are commendable at 20.9% and 20.4% respectively, indicating efficient use of equity and capital. Furthermore, the interest coverage ratio (ICR) of 11.64x suggests strong earnings relative to interest obligations, which is significantly higher than the finance sector average of approximately 5x, underscoring Emkay’s operational efficiency.
Balance Sheet Strength and Financial Ratios
Emkay’s balance sheet exhibits a solid foundation, with total reserves amounting to ₹278 Cr against borrowings of ₹68 Cr, resulting in a favorable debt-to-equity ratio of 0.17. This low leverage indicates minimal financial risk and suggests that the company can comfortably cover its debt obligations. The cash conversion cycle (CCC) has improved significantly, decreasing to 95 days in FY 2025, which is an improvement from 179 days in FY 2023. This efficiency in managing working capital is crucial for sustaining operational liquidity. Financial ratios such as the price-to-book value (P/BV) ratio at 1.20x further illustrate the company’s fair valuation relative to its equity, compared to the finance sector average of around 1.5x, indicating that Emkay is competitively priced.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Emkay Global Financial Services reveals a dominant promoter holding of 72.03%, which has slightly decreased from 74.49% over recent quarters, indicating a gradual dilution of control. Foreign Institutional Investors (FIIs) hold a modest 0.85%, while Domestic Institutional Investors (DIIs) have a negligible stake of 0.01%. The public shareholding has increased to 27.11%, reflecting growing retail investor interest. The number of shareholders has declined to 11,436, suggesting consolidation among investors. This pattern may indicate a shift in investor confidence, particularly as the company’s performance stabilizes and shows potential for growth. Increased public participation can lead to enhanced liquidity and market interest in the stock.
Outlook, Risks, and Final Insight
Looking ahead, Emkay Global Financial Services is poised for growth, with projected sales expected to reach ₹360 Cr by FY 2025. The company’s strong profitability metrics and efficient balance sheet provide a solid foundation for expansion. However, risks remain, including potential fluctuations in the financial markets and economic downturns that could impact revenue growth. Additionally, the company’s reliance on a concentrated promoter shareholding poses governance risks. Nevertheless, Emkay’s operational efficiency, indicated by its high ROE and ICR, along with an improving cash conversion cycle, positions it favorably. A balanced outlook suggests that while there are inherent risks, the company has the potential to deliver consistent growth, making it an attractive option for investors seeking exposure in the finance sector.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Emkay Global Financial Services Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Modern Shares & Stockbrokers Ltd | 12.7 Cr. | 43.5 | 67.7/36.4 | 45.5 | 43.5 | 0.00 % | 3.32 % | 1.74 % | 10.0 |
| Monarch Networth Capital Ltd | 2,462 Cr. | 311 | 495/280 | 15.9 | 102 | 0.32 % | 33.3 % | 26.2 % | 10.0 |
| Monotype India Ltd | 39.4 Cr. | 0.56 | 2.42/0.46 | 3.83 | 0.02 | 0.00 % | 286 % | % | 1.00 |
| Multipurpose Trading & Agencies Ltd | 4.69 Cr. | 9.46 | 13.3/8.25 | 10.3 | 0.00 % | 3.68 % | 3.38 % | 10.0 | |
| Munoth Financial Services Ltd | 29.5 Cr. | 57.5 | 72.0/48.0 | 20.6 | 0.00 % | 2.41 % | 3.38 % | 10.0 | |
| Industry Average | 6,860.57 Cr | 1,444.86 | 137.30 | 3,807.75 | 0.31% | 21.70% | 14.20% | 7.34 |
All Competitor Stocks of Emkay Global Financial Services Ltd
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 51.97 | 56.62 | 54.32 | 42.15 | 46.65 | 70.54 | 75.20 | 90.98 | 82.69 | 108.02 | 77.30 | 71.04 | 72.97 |
| Expenses | 43.22 | 46.98 | 47.91 | 53.99 | 52.21 | 62.98 | 64.70 | 78.10 | 67.61 | 78.93 | 67.87 | 70.93 | 67.14 |
| Operating Profit | 8.75 | 9.64 | 6.41 | -11.84 | -5.56 | 7.56 | 10.50 | 12.88 | 15.08 | 29.09 | 9.43 | 0.11 | 5.83 |
| OPM % | 16.84% | 17.03% | 11.80% | -28.09% | -11.92% | 10.72% | 13.96% | 14.16% | 18.24% | 26.93% | 12.20% | 0.15% | 7.99% |
| Other Income | 1.41 | 1.34 | 1.94 | 8.30 | 9.13 | 7.52 | 8.19 | 8.44 | 6.43 | 6.78 | 6.58 | 5.81 | 4.78 |
| Interest | 0.78 | 0.91 | 1.25 | 1.34 | 0.83 | 1.12 | 1.29 | 1.66 | 1.78 | 1.65 | 1.84 | 1.68 | 2.44 |
| Depreciation | 2.02 | 2.28 | 2.44 | 2.44 | 1.98 | 2.08 | 2.68 | 3.06 | 2.62 | 2.79 | 2.94 | 3.29 | 2.91 |
| Profit before tax | 7.36 | 7.79 | 4.66 | -7.32 | 0.76 | 11.88 | 14.72 | 16.60 | 17.11 | 31.43 | 11.23 | 0.95 | 5.26 |
| Tax % | 40.35% | 19.64% | -84.55% | -27.46% | 119.74% | 18.94% | 16.51% | 37.35% | 18.47% | 17.88% | 22.26% | -786.32% | 8.75% |
| Net Profit | 4.58 | 6.12 | 8.74 | -5.37 | 0.34 | 9.27 | 12.26 | 10.56 | 13.87 | 25.91 | 8.57 | 8.49 | 4.78 |
| EPS in Rs | 1.86 | 2.48 | 3.55 | -2.18 | 0.14 | 3.76 | 4.97 | 4.28 | 5.61 | 10.43 | 3.43 | 3.35 | 1.88 |
Last Updated: August 20, 2025, 11:10 am
Below is a detailed analysis of the quarterly data for Emkay Global Financial Services Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 72.97 Cr.. The value appears strong and on an upward trend. It has increased from 71.04 Cr. (Mar 2025) to 72.97 Cr., marking an increase of 1.93 Cr..
- For Expenses, as of Jun 2025, the value is 67.14 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 70.93 Cr. (Mar 2025) to 67.14 Cr., marking a decrease of 3.79 Cr..
- For Operating Profit, as of Jun 2025, the value is 5.83 Cr.. The value appears strong and on an upward trend. It has increased from 0.11 Cr. (Mar 2025) to 5.83 Cr., marking an increase of 5.72 Cr..
- For OPM %, as of Jun 2025, the value is 7.99%. The value appears strong and on an upward trend. It has increased from 0.15% (Mar 2025) to 7.99%, marking an increase of 7.84%.
- For Other Income, as of Jun 2025, the value is 4.78 Cr.. The value appears to be declining and may need further review. It has decreased from 5.81 Cr. (Mar 2025) to 4.78 Cr., marking a decrease of 1.03 Cr..
- For Interest, as of Jun 2025, the value is 2.44 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.68 Cr. (Mar 2025) to 2.44 Cr., marking an increase of 0.76 Cr..
- For Depreciation, as of Jun 2025, the value is 2.91 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3.29 Cr. (Mar 2025) to 2.91 Cr., marking a decrease of 0.38 Cr..
- For Profit before tax, as of Jun 2025, the value is 5.26 Cr.. The value appears strong and on an upward trend. It has increased from 0.95 Cr. (Mar 2025) to 5.26 Cr., marking an increase of 4.31 Cr..
- For Tax %, as of Jun 2025, the value is 8.75%. The value appears to be increasing, which may not be favorable. It has increased from -786.32% (Mar 2025) to 8.75%, marking an increase of 795.07%.
- For Net Profit, as of Jun 2025, the value is 4.78 Cr.. The value appears to be declining and may need further review. It has decreased from 8.49 Cr. (Mar 2025) to 4.78 Cr., marking a decrease of 3.71 Cr..
- For EPS in Rs, as of Jun 2025, the value is 1.88. The value appears to be declining and may need further review. It has decreased from 3.35 (Mar 2025) to 1.88, marking a decrease of 1.47.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: July 22, 2025, 3:54 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 82 | 117 | 105 | 109 | 156 | 147 | 135 | 160 | 272 | 215 | 314 | 360 |
| Expenses | 76 | 82 | 82 | 85 | 111 | 124 | 137 | 134 | 217 | 189 | 258 | 282 |
| Operating Profit | 6 | 34 | 24 | 24 | 45 | 23 | -3 | 26 | 55 | 25 | 56 | 79 |
| OPM % | 8% | 29% | 22% | 22% | 29% | 15% | -2% | 16% | 20% | 12% | 18% | 22% |
| Other Income | 1 | -36 | 0 | 0 | 0 | 3 | 0 | 2 | 1 | 1 | 2 | 1 |
| Interest | 5 | 5 | 4 | 3 | 4 | 7 | 7 | 3 | 3 | 4 | 5 | 7 |
| Depreciation | 4 | 4 | 4 | 4 | 5 | 7 | 8 | 8 | 8 | 9 | 10 | 12 |
| Profit before tax | -3 | -11 | 17 | 16 | 37 | 12 | -17 | 17 | 46 | 12 | 44 | 61 |
| Tax % | 40% | 49% | 28% | 26% | 22% | 31% | -29% | 32% | 24% | -12% | 27% | 6% |
| Net Profit | -4 | -16 | 12 | 12 | 29 | 9 | -13 | 11 | 34 | 14 | 32 | 57 |
| EPS in Rs | -1.62 | -6.44 | 4.92 | 4.99 | 11.66 | 3.55 | -5.11 | 4.52 | 13.72 | 5.71 | 13.14 | 22.40 |
| Dividend Payout % | 0% | 0% | 20% | 20% | 17% | 28% | 0% | 22% | 9% | 18% | 11% | 18% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -300.00% | 175.00% | 0.00% | 141.67% | -68.97% | -244.44% | 184.62% | 209.09% | -58.82% | 128.57% | 78.12% |
| Change in YoY Net Profit Growth (%) | 0.00% | 475.00% | -175.00% | 141.67% | -210.63% | -175.48% | 429.06% | 24.48% | -267.91% | 187.39% | -50.45% |
Emkay Global Financial Services Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 22% |
| 3 Years: | 10% |
| TTM: | 3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 46% |
| 3 Years: | 19% |
| TTM: | 4% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 31% |
| 3 Years: | 36% |
| 1 Year: | 19% |
| Return on Equity | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 14% |
| 3 Years: | 14% |
| Last Year: | 21% |
Last Updated: September 5, 2025, 3:30 am
Balance Sheet
Last Updated: July 25, 2025, 3:17 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 24 | 24 | 24 | 24 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 |
| Reserves | 105 | 89 | 98 | 111 | 137 | 142 | 128 | 142 | 176 | 186 | 216 | 278 |
| Borrowings | 34 | 35 | 11 | 49 | 34 | 23 | 10 | 17 | 44 | 33 | 52 | 68 |
| Other Liabilities | 110 | 112 | 92 | 116 | 169 | 136 | 218 | 381 | 519 | 488 | 772 | 862 |
| Total Liabilities | 274 | 261 | 226 | 299 | 365 | 326 | 381 | 565 | 764 | 731 | 1,065 | 1,233 |
| Fixed Assets | 39 | 36 | 35 | 35 | 33 | 35 | 38 | 34 | 32 | 38 | 43 | 41 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 |
| Investments | 3 | 4 | 11 | 26 | 36 | 28 | 16 | 29 | 34 | 24 | 26 | 32 |
| Other Assets | 232 | 221 | 180 | 237 | 296 | 263 | 327 | 501 | 696 | 669 | 996 | 1,160 |
| Total Assets | 274 | 261 | 226 | 299 | 365 | 326 | 381 | 565 | 764 | 731 | 1,065 | 1,233 |
Below is a detailed analysis of the balance sheet data for Emkay Global Financial Services Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 25.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 25.00 Cr..
- For Reserves, as of Mar 2025, the value is 278.00 Cr.. The value appears strong and on an upward trend. It has increased from 216.00 Cr. (Mar 2024) to 278.00 Cr., marking an increase of 62.00 Cr..
- For Borrowings, as of Mar 2025, the value is 68.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 52.00 Cr. (Mar 2024) to 68.00 Cr., marking an increase of 16.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 862.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 772.00 Cr. (Mar 2024) to 862.00 Cr., marking an increase of 90.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 1,233.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,065.00 Cr. (Mar 2024) to 1,233.00 Cr., marking an increase of 168.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 41.00 Cr.. The value appears to be declining and may need further review. It has decreased from 43.00 Cr. (Mar 2024) to 41.00 Cr., marking a decrease of 2.00 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Investments, as of Mar 2025, the value is 32.00 Cr.. The value appears strong and on an upward trend. It has increased from 26.00 Cr. (Mar 2024) to 32.00 Cr., marking an increase of 6.00 Cr..
- For Other Assets, as of Mar 2025, the value is 1,160.00 Cr.. The value appears strong and on an upward trend. It has increased from 996.00 Cr. (Mar 2024) to 1,160.00 Cr., marking an increase of 164.00 Cr..
- For Total Assets, as of Mar 2025, the value is 1,233.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,065.00 Cr. (Mar 2024) to 1,233.00 Cr., marking an increase of 168.00 Cr..
Notably, the Reserves (278.00 Cr.) exceed the Borrowings (68.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -28.00 | -1.00 | 13.00 | -25.00 | 11.00 | 0.00 | -13.00 | 9.00 | 11.00 | -8.00 | 4.00 | 11.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 173 | 169 | 66 | 218 | 208 | 146 | 145 | 152 | 119 | 179 | 145 | 95 |
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 173 | 169 | 66 | 218 | 208 | 146 | 145 | 152 | 119 | 179 | 145 | 95 |
| Working Capital Days | -6 | -59 | -161 | -172 | -150 | -134 | -353 | -564 | -372 | -380 | -463 | -271 |
| ROCE % | 2% | 19% | 14% | 12% | 22% | 9% | -6% | 12% | 23% | 7% | 17% | 20% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 13.16 | 5.71 | 13.72 | 4.52 | -5.12 |
| Diluted EPS (Rs.) | 12.74 | 5.68 | 12.97 | 4.52 | -5.12 |
| Cash EPS (Rs.) | 17.00 | 9.39 | 17.22 | 7.90 | -1.69 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 97.54 | 85.38 | 81.42 | 67.59 | 62.08 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 97.54 | 85.38 | 81.42 | 67.59 | 62.08 |
| Revenue From Operations / Share (Rs.) | 114.39 | 82.39 | 110.07 | 66.00 | 54.25 |
| PBDIT / Share (Rs.) | 23.13 | 10.55 | 23.07 | 12.30 | -0.81 |
| PBIT / Share (Rs.) | 19.16 | 6.83 | 20.00 | 9.20 | -3.94 |
| PBT / Share (Rs.) | 17.18 | 5.09 | 18.72 | 7.05 | -6.73 |
| Net Profit / Share (Rs.) | 13.03 | 5.66 | 14.15 | 4.80 | -4.82 |
| NP After MI And SOA / Share (Rs.) | 13.14 | 5.71 | 13.72 | 4.52 | -5.12 |
| PBDIT Margin (%) | 20.22 | 12.81 | 20.96 | 18.63 | -1.49 |
| PBIT Margin (%) | 16.75 | 8.28 | 18.16 | 13.94 | -7.27 |
| PBT Margin (%) | 15.01 | 6.17 | 17.00 | 10.68 | -12.40 |
| Net Profit Margin (%) | 11.39 | 6.87 | 12.85 | 7.28 | -8.89 |
| NP After MI And SOA Margin (%) | 11.48 | 6.93 | 12.46 | 6.85 | -9.42 |
| Return on Networth / Equity (%) | 13.46 | 6.69 | 16.84 | 6.69 | -8.23 |
| Return on Capital Employeed (%) | 15.98 | 6.82 | 18.20 | 11.91 | -5.77 |
| Return On Assets (%) | 3.04 | 1.92 | 4.42 | 1.97 | -3.30 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.14 | 0.01 | 0.01 |
| Total Debt / Equity (X) | 0.17 | 0.12 | 0.19 | 0.07 | 0.06 |
| Asset Turnover Ratio (%) | 0.31 | 0.26 | 0.27 | 0.31 | 0.35 |
| Current Ratio (X) | 1.31 | 1.38 | 1.46 | 1.38 | 1.52 |
| Quick Ratio (X) | 1.31 | 1.38 | 1.46 | 1.38 | 1.51 |
| Dividend Payout Ratio (NP) (%) | 7.59 | 21.88 | 7.28 | 0.00 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 5.83 | 13.24 | 5.94 | 0.00 | 0.00 |
| Earning Retention Ratio (%) | 92.41 | 78.12 | 92.72 | 0.00 | 0.00 |
| Cash Earning Retention Ratio (%) | 94.17 | 86.76 | 94.06 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 11.64 | 6.08 | 18.01 | 5.73 | -0.29 |
| Interest Coverage Ratio (Post Tax) (X) | 7.24 | 4.27 | 12.06 | 3.24 | -0.70 |
| Enterprise Value (Cr.) | -251.00 | -164.08 | -116.33 | -163.84 | -142.50 |
| EV / Net Operating Revenue (X) | -0.88 | -0.80 | -0.42 | -1.01 | -1.07 |
| EV / EBITDA (X) | -4.39 | -6.31 | -2.05 | -5.41 | 71.33 |
| MarketCap / Net Operating Revenue (X) | 1.02 | 0.78 | 0.94 | 0.98 | 0.46 |
| Retention Ratios (%) | 92.40 | 78.11 | 92.71 | 0.00 | 0.00 |
| Price / BV (X) | 1.20 | 0.75 | 1.28 | 0.96 | 0.40 |
| Price / Net Operating Revenue (X) | 1.02 | 0.78 | 0.94 | 0.98 | 0.46 |
| EarningsYield | 0.11 | 0.08 | 0.13 | 0.06 | -0.20 |
After reviewing the key financial ratios for Emkay Global Financial Services Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 24, the value is 13.16. This value is within the healthy range. It has increased from 5.71 (Mar 23) to 13.16, marking an increase of 7.45.
- For Diluted EPS (Rs.), as of Mar 24, the value is 12.74. This value is within the healthy range. It has increased from 5.68 (Mar 23) to 12.74, marking an increase of 7.06.
- For Cash EPS (Rs.), as of Mar 24, the value is 17.00. This value is within the healthy range. It has increased from 9.39 (Mar 23) to 17.00, marking an increase of 7.61.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 97.54. It has increased from 85.38 (Mar 23) to 97.54, marking an increase of 12.16.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 97.54. It has increased from 85.38 (Mar 23) to 97.54, marking an increase of 12.16.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 114.39. It has increased from 82.39 (Mar 23) to 114.39, marking an increase of 32.00.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 23.13. This value is within the healthy range. It has increased from 10.55 (Mar 23) to 23.13, marking an increase of 12.58.
- For PBIT / Share (Rs.), as of Mar 24, the value is 19.16. This value is within the healthy range. It has increased from 6.83 (Mar 23) to 19.16, marking an increase of 12.33.
- For PBT / Share (Rs.), as of Mar 24, the value is 17.18. This value is within the healthy range. It has increased from 5.09 (Mar 23) to 17.18, marking an increase of 12.09.
- For Net Profit / Share (Rs.), as of Mar 24, the value is 13.03. This value is within the healthy range. It has increased from 5.66 (Mar 23) to 13.03, marking an increase of 7.37.
- For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 13.14. This value is within the healthy range. It has increased from 5.71 (Mar 23) to 13.14, marking an increase of 7.43.
- For PBDIT Margin (%), as of Mar 24, the value is 20.22. This value is within the healthy range. It has increased from 12.81 (Mar 23) to 20.22, marking an increase of 7.41.
- For PBIT Margin (%), as of Mar 24, the value is 16.75. This value is within the healthy range. It has increased from 8.28 (Mar 23) to 16.75, marking an increase of 8.47.
- For PBT Margin (%), as of Mar 24, the value is 15.01. This value is within the healthy range. It has increased from 6.17 (Mar 23) to 15.01, marking an increase of 8.84.
- For Net Profit Margin (%), as of Mar 24, the value is 11.39. This value exceeds the healthy maximum of 10. It has increased from 6.87 (Mar 23) to 11.39, marking an increase of 4.52.
- For NP After MI And SOA Margin (%), as of Mar 24, the value is 11.48. This value is within the healthy range. It has increased from 6.93 (Mar 23) to 11.48, marking an increase of 4.55.
- For Return on Networth / Equity (%), as of Mar 24, the value is 13.46. This value is below the healthy minimum of 15. It has increased from 6.69 (Mar 23) to 13.46, marking an increase of 6.77.
- For Return on Capital Employeed (%), as of Mar 24, the value is 15.98. This value is within the healthy range. It has increased from 6.82 (Mar 23) to 15.98, marking an increase of 9.16.
- For Return On Assets (%), as of Mar 24, the value is 3.04. This value is below the healthy minimum of 5. It has increased from 1.92 (Mar 23) to 3.04, marking an increase of 1.12.
- For Long Term Debt / Equity (X), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 23) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 24, the value is 0.17. This value is within the healthy range. It has increased from 0.12 (Mar 23) to 0.17, marking an increase of 0.05.
- For Asset Turnover Ratio (%), as of Mar 24, the value is 0.31. It has increased from 0.26 (Mar 23) to 0.31, marking an increase of 0.05.
- For Current Ratio (X), as of Mar 24, the value is 1.31. This value is below the healthy minimum of 1.5. It has decreased from 1.38 (Mar 23) to 1.31, marking a decrease of 0.07.
- For Quick Ratio (X), as of Mar 24, the value is 1.31. This value is within the healthy range. It has decreased from 1.38 (Mar 23) to 1.31, marking a decrease of 0.07.
- For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 7.59. This value is below the healthy minimum of 20. It has decreased from 21.88 (Mar 23) to 7.59, marking a decrease of 14.29.
- For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 5.83. This value is below the healthy minimum of 20. It has decreased from 13.24 (Mar 23) to 5.83, marking a decrease of 7.41.
- For Earning Retention Ratio (%), as of Mar 24, the value is 92.41. This value exceeds the healthy maximum of 70. It has increased from 78.12 (Mar 23) to 92.41, marking an increase of 14.29.
- For Cash Earning Retention Ratio (%), as of Mar 24, the value is 94.17. This value exceeds the healthy maximum of 70. It has increased from 86.76 (Mar 23) to 94.17, marking an increase of 7.41.
- For Interest Coverage Ratio (X), as of Mar 24, the value is 11.64. This value is within the healthy range. It has increased from 6.08 (Mar 23) to 11.64, marking an increase of 5.56.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 7.24. This value is within the healthy range. It has increased from 4.27 (Mar 23) to 7.24, marking an increase of 2.97.
- For Enterprise Value (Cr.), as of Mar 24, the value is -251.00. It has decreased from -164.08 (Mar 23) to -251.00, marking a decrease of 86.92.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is -0.88. This value is below the healthy minimum of 1. It has decreased from -0.80 (Mar 23) to -0.88, marking a decrease of 0.08.
- For EV / EBITDA (X), as of Mar 24, the value is -4.39. This value is below the healthy minimum of 5. It has increased from -6.31 (Mar 23) to -4.39, marking an increase of 1.92.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 1.02. This value is within the healthy range. It has increased from 0.78 (Mar 23) to 1.02, marking an increase of 0.24.
- For Retention Ratios (%), as of Mar 24, the value is 92.40. This value exceeds the healthy maximum of 70. It has increased from 78.11 (Mar 23) to 92.40, marking an increase of 14.29.
- For Price / BV (X), as of Mar 24, the value is 1.20. This value is within the healthy range. It has increased from 0.75 (Mar 23) to 1.20, marking an increase of 0.45.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 1.02. This value is within the healthy range. It has increased from 0.78 (Mar 23) to 1.02, marking an increase of 0.24.
- For EarningsYield, as of Mar 24, the value is 0.11. This value is below the healthy minimum of 5. It has increased from 0.08 (Mar 23) to 0.11, marking an increase of 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Emkay Global Financial Services Ltd:
- Net Profit Margin: 11.39%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 15.98% (Industry Average ROCE: 21.7%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 13.46% (Industry Average ROE: 14.2%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 7.24
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.31
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 17.1 (Industry average Stock P/E: 137.3)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.17
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 11.39%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Finance & Investments | The Ruby, 7th Floor, Mumbai Maharashtra 400028 | secretarial@emkayglobal.com http://www.emkayglobal.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. S K Saboo | Chairman |
| Mr. Krishna Kumar Karwa | Managing Director |
| Mr. Prakash Kacholia | Managing Director |
| Mr. Raunak Karwa | Non Executive Director |
| Dr. Bharat Kumar Singh | Independent Director |
| Dr. Satish Ugrankar | Independent Director |
| Mr. A Dhananjaya | Independent Director |
| Mrs. Hutokshi Wadia | Independent Woman Director |
FAQ
What is the intrinsic value of Emkay Global Financial Services Ltd?
Emkay Global Financial Services Ltd's intrinsic value (as of 09 October 2025) is 344.71 which is 8.74% higher the current market price of 317.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹815 Cr. market cap, FY2025-2026 high/low of 410/162, reserves of ₹278 Cr, and liabilities of 1,233 Cr.
What is the Market Cap of Emkay Global Financial Services Ltd?
The Market Cap of Emkay Global Financial Services Ltd is 815 Cr..
What is the current Stock Price of Emkay Global Financial Services Ltd as on 09 October 2025?
The current stock price of Emkay Global Financial Services Ltd as on 09 October 2025 is 317.
What is the High / Low of Emkay Global Financial Services Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Emkay Global Financial Services Ltd stocks is 410/162.
What is the Stock P/E of Emkay Global Financial Services Ltd?
The Stock P/E of Emkay Global Financial Services Ltd is 17.1.
What is the Book Value of Emkay Global Financial Services Ltd?
The Book Value of Emkay Global Financial Services Ltd is 120.
What is the Dividend Yield of Emkay Global Financial Services Ltd?
The Dividend Yield of Emkay Global Financial Services Ltd is 0.47 %.
What is the ROCE of Emkay Global Financial Services Ltd?
The ROCE of Emkay Global Financial Services Ltd is 20.4 %.
What is the ROE of Emkay Global Financial Services Ltd?
The ROE of Emkay Global Financial Services Ltd is 20.9 %.
What is the Face Value of Emkay Global Financial Services Ltd?
The Face Value of Emkay Global Financial Services Ltd is 10.0.